Leal AF - Search Results

1

Mucopolysaccharidosis IVA: Current Disease Models and Drawbacks.

Leal AF, Alméciga-Díaz CJ, Tomatsu S. Leal AF, et al. Int J Mol Sci. 2023 Nov 9;24(22):16148. doi: 10.3390/ijms242216148. Int J Mol Sci. 2023. PMID: 38003337 Free PMC article. Review.

2

Lysosomal storage diseases: current therapies and future alternatives.

Leal AF, Espejo-Mojica AJ, Sánchez OF, Ramírez CM, Reyes LH, Cruz JC, Alméciga-Díaz CJ. Leal AF, et al. J Mol Med (Berl). 2020 Jul;98(7):931-946. doi: 10.1007/s00109-020-01935-6. Epub 2020 Jun 11. J Mol Med (Berl). 2020. PMID: 32529345 Review.

3

GM2 Gangliosidoses: Clinical Features, Pathophysiological Aspects, and Current Therapies.

Leal AF, Benincore-Flórez E, Solano-Galarza D, Garzón Jaramillo RG, Echeverri-Peña OY, Suarez DA, Alméciga-Díaz CJ, Espejo-Mojica AJ. Leal AF, et al. Int J Mol Sci. 2020 Aug 27;21(17):6213. doi: 10.3390/ijms21176213. Int J Mol Sci. 2020. PMID: 32867370 Free PMC article. Review.

4

Efficient CRISPR/Cas9 nickase-mediated genome editing in an in vitro model of mucopolysaccharidosis IVA.

Leal AF, Alméciga-Díaz CJ. Leal AF, et al. Gene Ther. 2023 Feb;30(1-2):107-114. doi: 10.1038/s41434-022-00344-3. Epub 2022 May 18. Gene Ther. 2023. PMID: 35581402

5

Hematological Findings in Lysosomal Storage Disorders: A Perspective from the Medical Laboratory.

Leal AF, Nieto WG, Candelo E, Pachajoa H, Alméciga-Díaz CJ. Leal AF, et al. EJIFCC. 2022 Apr 11;33(1):28-42. eCollection 2022 Apr. EJIFCC. 2022. PMID: 35645695 Free PMC article.

6

Sphingolipids and their role in health and disease in the central nervous system.

Leal AF, Suarez DA, Echeverri-Peña OY, Albarracín SL, Alméciga-Díaz CJ, Espejo-Mojica ÁJ. Leal AF, et al. Adv Biol Regul. 2022 Aug;85:100900. doi: 10.1016/j.jbior.2022.100900. Epub 2022 Jul 15. Adv Biol Regul. 2022. PMID: 35870382 Review.

7

Delivery and assessment of a CRISPR/nCas9-based genome editing system on in vitro models of mucopolysaccharidoses IVA assisted by magnetite-based nanoparticles.

Leal AF, Cifuentes J, Torres CE, Suárez D, Quezada V, Gómez SC, Cruz JC, Reyes LH, Espejo-Mojica AJ, Alméciga-Díaz CJ. Leal AF, et al. Sci Rep. 2022 Sep 3;12(1):15045. doi: 10.1038/s41598-022-19407-x. Sci Rep. 2022. PMID: 36057729 Free PMC article.

8

CRISPR/nCas9-Based Genome Editing on GM2 Gangliosidoses Fibroblasts via Non-Viral Vectors.

Leal AF, Cifuentes J, Quezada V, Benincore-Flórez E, Cruz JC, Reyes LH, Espejo-Mojica AJ, Alméciga-Díaz CJ. Leal AF, et al. Int J Mol Sci. 2022 Sep 14;23(18):10672. doi: 10.3390/ijms231810672. Int J Mol Sci. 2022. PMID: 36142595 Free PMC article.

9

Regulation of Molecular Targets in Osteosarcoma Treatment.

Celik B, Cicek K, Leal AF, Tomatsu S. Celik B, et al. Among authors: leal af. Int J Mol Sci. 2022 Oct 20;23(20):12583. doi: 10.3390/ijms232012583. Int J Mol Sci. 2022. PMID: 36293439 Free PMC article. Review.

10

The landscape of CRISPR/Cas9 for inborn errors of metabolism.

Leal AF, Fnu N, Benincore-Flórez E, Herreño-Pachón AM, Echeverri-Peña OY, Alméciga-Díaz CJ, Tomatsu S. Leal AF, et al. Mol Genet Metab. 2023 Jan;138(1):106968. doi: 10.1016/j.ymgme.2022.106968. Epub 2022 Dec 7. Mol Genet Metab. 2023. PMID: 36525790 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

62 results

Search Page